author-photo

David Lorente Estelles

13

Papers

54

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Abstract P3-09-06: Bintrafusp alfa (M7824), a bifunctional fusion protein targeting transforming growth factor-β and programmed death ligand 1, in advanced triple-negative breast cancer: Preliminary results from a phase 1 cohort

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
281 JAVELIN Medley VEGF: phase 2 study of avelumab + axitinib in patients with previously treated non-small cell lung cancer (NSCLC) or treatment naive, cisplatin-ineligible urothelial cancer (UC)

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (2)
Molecular pathology and prostate cancer therapeutics: from biology to bedside

2014 The Journal of Pathology
Show All
- Source
- Cite
- Save
Citations (28)
Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience

2014 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (8)